| Literature DB >> 35791642 |
Guangyu Wang1, Xinyu Song1, Guangjun Li1, Lian Duan1, Zhibin Li2, Guyu Dai1, Long Bai1, Qing Xiao1, Xiangbin Zhang1, Ying Song1, Sen Bai1.
Abstract
Purpose: Surface-guided radiation therapy (SGRT) application has limitations. This study aimed to explore the relationship between patient characteristics and their external/internal correlation to qualitatively assess the external/internal correlation in a particular patient.Entities:
Keywords: Spearman correlation coefficient; external/internal correlation; liver cancer; lung cancer; tumor motion
Mesh:
Year: 2022 PMID: 35791642 PMCID: PMC9272160 DOI: 10.1177/15330338221112280
Source DB: PubMed Journal: Technol Cancer Res Treat ISSN: 1533-0338
Basic Data for the 90 Cancer Patients Assessed in This Study.
| Patients | Characteristics | Values | |
|---|---|---|---|
| Liver cancer (41 patients, 59 tumors in total) | Motion magnitude of internal tumor Ai in 3 directions (cm) | S-I | 0.916 ± 0.457 |
| A-P | 0.321 ± 0.214 | ||
| R-L | 0.242 ± 0.177 | ||
| Motion magnitude of the external marker Ae (cm) | 0.908 ± 0.272 | ||
| Tumor volume Vt (cm3) | 197.3 ± 327.7 | ||
| Age (years) | 56.7 ± 13.0 | ||
| Gender | male : female | 22:19 | |
| Lung cancer (49 patients, 70 tumors in total) | Motion magnitude of internal tumor Ai in 3 directions (cm) | S-I | 0.905 ± 0.264 |
| A-P | 0.306 ± 0.264 | ||
| R-L | 0.223 ± 0.264 | ||
| Motion magnitude of the external marker Ae (cm) | 0.964 ± 13.903 | ||
| Tumor volume Vt (cm3) | 18.4 ± 41.8 | ||
| Age (years) | 57.5 ± 0.3 | ||
| Gender | male : female | 27:22 | |
| The type of location | central : peripheral | 23:47 | |
Spearman Correlation Coefficients and Significance Scores Between External/Internal Correlation and Patient Characteristics.
| Ai | Ae | Vt | Age | ||
|---|---|---|---|---|---|
| Liver cancer patients | |||||
| S-I | SCC | 0.199 | 0.077 | 0.118 | −0.358** |
| SCCsvr | 0.235 | 0.063 | 0.056 | −0.372** | |
| A-P | SCC | 0.109 | 0.306* | 0.129 | −0.076 |
| SCCsvr | 0.234 | 0.351** | 0.195 | −0.121 | |
| R-L | SCC | −0.243 | −0.184 | 0.060 | 0.111 |
| SCCsvr | −0.03 | −0.106 | 0.191 | 0.036 | |
| Lung cancer patients | |||||
| S-I | SCC | 0.386** | 0.452** | −0.191 | −0.069 |
| SCCsvr | 0.494** | 0.468** | −0.119 | −0.180 | |
| A-P | SCC | 0.246* | 0.136 | −0.038 | −0.163 |
| SCCsvr | 0.062 | 0.395** | −0.013 | −0.197 | |
| R-L | SCC | 0.307* | −0.042 | −0.173 | −0.032 |
| SCCsvr | 0.154 | 0.375** | −0.148 | −0.125 | |
* P<.05.
** P<.01.
Figure 1.External/internal correlations in (a) liver and (b) lung cancer patients. Red and blue dots indicate SCC and SCCsvr values, respectively.
Proportions of Liver and Lung Cancer Patients With Different SCC and SCCsvr Scores.
| S-I | A-P | R-L | ||||
|---|---|---|---|---|---|---|
| SCC | SCCsvr | SCC | SCCsvr | SCC | SCCsvr | |
| Liver cancer patients | ||||||
| Weak | 1.7% | 0.0% | 6.8% | 1.7% | 15.3% | 10.2% |
| Moderate | 5.1% | 3.4% | 28.8% | 23.7% | 37.3% | 35.6% |
| Strong | 93.2% | 96.6% | 64.4% | 74.6% | 47.4% | 54.2% |
| Lung cancer patients | ||||||
| Weak | 11.4% | 7.1% | 15.7% | 0.0% | 15.7% | 0.0% |
| Moderate | 12.9% | 11.4% | 44.3% | 8.6% | 35.7% | 7.1% |
| Strong | 75.7% | 81.5% | 40.0% | 91.4% | 48.6% | 92.9% |
Figure 2.(I) SCC and SCCsvr scores for each patient. Solid and dotted lines indicate SCC and SCCsvr scores, respectively. (II) Deviations between SCC and SCCsvr in (a) liver and (b) lung cancer patients in the SI, AP, and LR directions, which are plotted in different colors. The solid line of the same color corresponds to the mean deviation value.
Figure 3.(a) Liver and (b) lung cancer patient characteristics with different levels of SCCsvr scores. A P value of .05 was defined as statistically significant.
Figure 4.External/internal correlations and other characteristics of (a) liver and (b) lung cancer patients of different genders in the SI, AP, and LR directions. The box represents that the values lie between 25% and 75% and the middle line the mean value of each characteristic.
Figure 5.External/internal correlations of patients with central/peripheral lung cancers. A P value of .05 was defined as statistically significant.